Exosomes derived from the TGF-β1 gene-modified bone marrow DC (TGF-β1-EXO) have inhibited Th17 responses and upregulated regulatory T cells, playing a protective role during IBD development in a murine model. Here, TGFB1 is linked to inflammatory bowel disease.